IRVINE, CA: Allergan has selected GCI Health to support the launch of Botox for the preventative treatment of headaches, which was approved by the FDA on October 15 for use in adults with chronic migraines.
Caroline Van Hove, VP, corporate communications for Allergan, told PRWeek the agency won the account following a competitive review.
“The agencies we looked at all needed to have substantial expertise in the headache and migraine area as well as women's health issues,” said Van Hove.
She ...